Heart Health · Lipid Biomarkers

Lipoprotein(a): How Much Should You Actually Take?

There's no supplement dose that reliably lowers Lp(a) — here's the test-first, risk-based strategy that actually works.

If you've searched for an Lp(a) "dosage," you're asking a reasonable question that doesn't have a simple pill-based answer — and understanding why is the first step toward actually managing your risk.

What Lipoprotein(a) Actually Is — And Why "Dosage" Is the Wrong Question

Before talking numbers, it helps to understand what you're dealing with. Lipoprotein(a), or Lp(a), is a genetically determined particle in your blood — a cholesterol-carrying LDL-like structure wrapped in a sticky protein called apolipoprotein(a). Unlike LDL cholesterol, which responds predictably to diet, exercise, and statins, Lp(a) levels are set almost entirely by your DNA and stay remarkably stable across your lifetime.

This matters because the phrase "how much should I take" implies a supplement or medication you dose up or down to hit a target. For Lp(a), that's not quite how biology works — at least not yet. There is currently no FDA-approved drug or supplement specifically designed to lower Lp(a), which makes dosing conversations fundamentally different from something like vitamin D or omega-3s.

There's No Established "Lp(a) Supplement" Dose — Here's What the Research Actually Supports

Several nutrients and compounds have been studied for modest effects on Lp(a), but none carry a validated, standardized dosing protocol the way statins do for LDL. Niacin (vitamin B3) in high doses — historically 1,000–3,000 mg per day under physician supervision — has shown Lp(a) reductions of roughly 20–30% in older trials, but it also comes with flushing, liver enzyme changes, and no proven reduction in cardiovascular events specifically from lowering Lp(a). Most cardiologists no longer recommend high-dose niacin for this purpose alone.

L-carnitine (typically 1–2 grams daily in studies) and CoQ10 have shown small, inconsistent effects on Lp(a) in limited trials. Omega-3 fatty acids, particularly EPA/DHA at 2–4 grams per day, support overall cardiovascular risk markers but have not reliably demonstrated meaningful Lp(a) reduction. Vitamin C and lysine combinations, popularized decades ago, lack rigorous modern trial support despite enduring internet popularity.

Lipoprotein(A): How Much Should You Take?

The Real Answer: Test First, Then Build a Strategy Around Your Number

Because Lp(a) is inherited and largely fixed, the most important "dose" decision isn't about a pill — it's about getting tested so you and your physician know your baseline. Lp(a) is measured once in most people's lives unless a provider has a specific reason to recheck it. Levels are typically reported in nmol/L or mg/dL, and anything above roughly 125 nmol/L (or about 50 mg/dL) is generally considered elevated and associated with increased cardiovascular risk.

PersonaLabs · At-Home Lab Testing

Know Your Number Before You Guess at a Protocol

PersonaLabs offers physician-ordered Lp(a) and advanced lipid panels you can schedule at a local draw site — no guesswork, just a clear baseline reading to guide every decision that follows.

Check Lp(a) Testing Options →
Lp(a) Level (nmol/L)Risk CategoryGeneral Guidance
Under 75Low / NormalRoutine monitoring, no specific action needed
75–125BorderlineDiscuss family history and overall cardiovascular risk with your doctor
125–200HighConsider aggressive management of other risk factors (LDL, blood pressure, smoking)
Above 200Very HighSpecialist referral often recommended; emerging therapies may be discussed
Lipoprotein(A): How Much Should You Take?

What "Treatment Dosing" Looks Like When Lp(a) Is Elevated

If your number comes back high, the conversation shifts from supplements to a broader risk-reduction strategy, because you can't yet directly and reliably lower Lp(a) with an over-the-counter dose. Instead, physicians typically focus on aggressively managing the risk factors you *can* control:

PCSK9 Inhibitors: A Partial, Prescription-Only Option

For some patients with very high Lp(a) and additional cardiovascular risk, physicians may prescribe PCSK9 inhibitor injections, which were developed primarily to lower LDL but have shown a secondary 20–25% reduction in Lp(a) in some studies. Dosing here is strictly physician-directed — typically a subcutaneous injection every two to four weeks — and is not something to self-manage or source outside a prescription relationship.

EmpowerDx · Specialty Lab Panels

Pair Lp(a) With a Full Cardiometabolic Panel

EmpowerDx makes it simple to bundle Lp(a) testing with ApoB, hs-CRP, and a standard lipid panel in one draw, giving your physician the fuller picture needed to build an actual risk-reduction plan.

Explore Cardiometabolic Panels →

Supporting Habits Worth "Dosing" Daily — Even Without a Magic Pill

While nothing over-the-counter reliably moves the Lp(a) number itself, daily habits still meaningfully shift your overall cardiovascular risk, which is ultimately what matters for long-term health outcomes. A Mediterranean-style eating pattern, regular aerobic exercise (generally 150+ minutes weekly), adequate sleep, and stress management all support healthier LDL particle behavior, blood pressure, and inflammation — all of which interact with elevated Lp(a) to determine real-world risk.

Many people with high Lp(a) also choose to track omega-3 intake (commonly 1–2 grams EPA/DHA daily from food or supplements) and ensure consistent magnesium and CoQ10 intake as general cardiovascular support, even though neither is proven to directly lower Lp(a) itself.

Amazon · Cardiovascular Support

Daily Omega-3 and CoQ10 Support

A high-quality, third-party-tested omega-3 and CoQ10 combination can support overall cardiovascular health markers as part of a broader Lp(a) risk-management routine.

Shop Omega-3 & CoQ10 Options →

The Bottom Line on "Dosing" Lp(a)

There is no supplement dose, no capsule count, and no daily gram target that reliably lowers Lp(a) today. The real protocol is: test once to know your number, interpret it in context with a physician, aggressively manage every other modifiable risk factor, and stay informed as targeted therapies move through clinical trials toward approval in the coming years. Treat Lp(a) less like a nutrient you titrate and more like a genetic risk marker you respect and plan around — that mindset shift is the single most useful "dose" of information you can give yourself in 2026.

From across the network

More from the network on related topics: VitaminSupplyCenter · TestBoostLab · EliteRecoveryLab.

Important: Educational information only, not medical advice. Lab results and wearable data should be interpreted with a qualified provider. Some links on this page are affiliate links; if you buy through them we may earn a commission at no additional cost to you — it never changes our recommendations.